Source:http://linkedlifedata.com/resource/pubmed/id/10478463
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0000854,
umls-concept:C0007560,
umls-concept:C0033262,
umls-concept:C0205177,
umls-concept:C0205314,
umls-concept:C0205531,
umls-concept:C0220781,
umls-concept:C0226896,
umls-concept:C0439849,
umls-concept:C0442027,
umls-concept:C0679622,
umls-concept:C0871161,
umls-concept:C0968379,
umls-concept:C1527415,
umls-concept:C1883254
|
pubmed:issue |
8
|
pubmed:dateCreated |
1999-10-22
|
pubmed:abstractText |
Ceftizoxime (CZX), a parenteral cephalosporin, has potent and broad antibacterial activity. To improve its oral absorption, we synthesized a series of monofunctional and bifunctional prodrugs of CZX. In rabbits, urinary recovery after oral administration of CZX was improved by esterification of the carboxyl group at the C-4 position with various lipophilic moieties (monofunctional prodrugs), and was further increased by introduction of a hydrophilic L-alanine to the amino group on the thiazole ring at the C-7 position (bifunctional prodrugs). Least-squares analysis showed good parabolic correlations between log P and urinary recovery for monofunctional and bifunctional prodrugs, respectively. AS-924, a bifunctional prodrug with a pivaloyloxymethyl and L-alanyl moiety had the best balance of lipophilicity and water-solubility for oral absorption among the prodrugs synthesized.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0009-2363
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
47
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1081-8
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:10478463-Administration, Oral,
pubmed-meshheading:10478463-Amino Acids,
pubmed-meshheading:10478463-Animals,
pubmed-meshheading:10478463-Area Under Curve,
pubmed-meshheading:10478463-Ceftizoxime,
pubmed-meshheading:10478463-Cephalosporins,
pubmed-meshheading:10478463-Chemistry, Physical,
pubmed-meshheading:10478463-Dogs,
pubmed-meshheading:10478463-Intestinal Absorption,
pubmed-meshheading:10478463-Male,
pubmed-meshheading:10478463-Physicochemical Phenomena,
pubmed-meshheading:10478463-Prodrugs,
pubmed-meshheading:10478463-Rabbits,
pubmed-meshheading:10478463-Solubility
|
pubmed:year |
1999
|
pubmed:articleTitle |
AS-924, a novel orally active bifunctional prodrug of ceftizoxime. Synthesis and relationship between physicochemical properties and oral absorption.
|
pubmed:affiliation |
Research Laboratories, Kyoto Pharmaceutical Industries, Ltd., Japan.
|
pubmed:publicationType |
Journal Article,
In Vitro
|